Cargando…

Good reasons for targeting SARS-CoV-2 by engineered extracellular vesicles

[Figure: see text]

Detalles Bibliográficos
Autores principales:	de Marco, Ario, Barile, Lucio
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Society of Gene & Cell Therapy 2022
Materias:	Editorial
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8917268/ https://www.ncbi.nlm.nih.gov/pubmed/35317050 http://dx.doi.org/10.1016/j.omtm.2022.02.003

Ejemplares similares

Circulating extracellular vesicles are endowed with enhanced procoagulant activity in SARS-CoV-2 infection
por: Balbi, Carolina, et al.
Publicado: (2021)

Engineered extracellular vesicles directed to the spike protein inhibit SARS-CoV-2
por: Scott, Tristan A., et al.
Publicado: (2022)

Neutralization of SARS-CoV-2 pseudovirus using ACE2-engineered extracellular vesicles
por: Wu, Canhao, et al.
Publicado: (2022)

Risk stratification of patients with SARS-CoV-2 by tissue factor expression in circulating extracellular vesicles
por: Burrello, Jacopo, et al.
Publicado: (2022)

Extracellular Vesicle-Based SARS-CoV-2 Vaccine
por: Matsuzaka, Yasunari, et al.
Publicado: (2023)

Engineered extracellular vesicles antagonize SARS-CoV-2 infection by inhibiting mTOR signaling
por: Ibrahim, A.G., et al.
Publicado: (2022)

Activation of Anti-SARS-CoV-2 Human CTLs by Extracellular Vesicles Engineered with the N Viral Protein
por: Manfredi, Francesco, et al.
Publicado: (2022)

Quantitative proteomics and biological activity of extracellular vesicles engineered to express SARS‐CoV‐2 spike protein
por: Choi, Dongsic, et al.
Publicado: (2022)

Incidence rate of MIS‐C in paediatrics: A good reason to vaccinate children against SARS‐CoV‐2
por: Castagnola, Elio, et al.
Publicado: (2021)

A Role for Extracellular Vesicles in SARS-CoV-2 Therapeutics and Prevention
por: Machhi, Jatin, et al.
Publicado: (2021)

Extracellular vesicles mediate antibody-resistant transmission of SARS-CoV-2
por: Xia, Bingqing, et al.
Publicado: (2023)

Engineered small extracellular vesicles displaying ACE2 variants on the surface protect against SARS‐CoV‐2 infection
por: Kim, Hark Kyun, et al.
Publicado: (2022)

Genetically Engineered MRI-Trackable Extracellular Vesicles as SARS-CoV-2 Mimetics for Mapping ACE2 Binding In Vivo
por: Galisova, Andrea, et al.
Publicado: (2022)

Antiviral effect of SARS-CoV-2 N-specific CD8(+) T cells induced in lungs by engineered extracellular vesicles
por: Manfredi, Francesco, et al.
Publicado: (2023)

Hitting the Bullseye: Are extracellular vesicles on target?
por: Noren Hooten, Nicole, et al.
Publicado: (2020)

Salivary extracellular vesicles inhibit Zika virus but not SARS-CoV-2 infection
por: Conzelmann, Carina, et al.
Publicado: (2020)

Procoagulant activity of extracellular vesicles in plasma of patients with SARS-CoV-2 infection
por: Theresa, L., et al.
Publicado: (2021)

Extracellular vesicles: A promising therapy against SARS-CoV-2 infection
por: Leyfman, Yan, et al.
Publicado: (2023)

Musculoskeletal symptoms in SARS-CoV-2 (COVID-19) patients
por: Cipollaro, Lucio, et al.
Publicado: (2020)

Promising Extracellular Vesicle-Based Vaccines against Viruses, Including SARS-CoV-2
por: Sabanovic, Berina, et al.
Publicado: (2021)

Liposome-mediated detection of SARS-CoV-2 RNA-positive extracellular vesicles in plasma
por: Ning, Bo, et al.
Publicado: (2021)

Extracellular Vesicles as Bridges Between Host Immune Cells and Graft Organ During Cellular Rejection
por: Barile, Lucio
Publicado: (2023)

SARS-CoV-2: To be or not to be vaccinated?
por: Beauchet, Olivier
Publicado: (2021)

SARS-CoV-2 docet
por: Sarli, Leopoldo
Publicado: (2021)

Targeting SARS-CoV-2 using polycomb inhibitors as antiviral agents
por: Ayaz, Sameer, et al.
Publicado: (2020)

SARS-CoV-2-induced senescence as a potential therapeutic target
por: Denholm, Mary, et al.
Publicado: (2022)

Extracellular vesicles carry SARS‐CoV‐2 spike protein and serve as decoys for neutralizing antibodies
por: Troyer, Zach, et al.
Publicado: (2021)

Anti-SARS-CoV-2 Activity of Extracellular Vesicle Inhibitors: Screening, Validation, and Combination with Remdesivir
por: Kongsomros, Supasek, et al.
Publicado: (2021)

Circulating ACE2-expressing extracellular vesicles block broad strains of SARS-CoV-2
por: El-Shennawy, Lamiaa, et al.
Publicado: (2022)

Investigation of Extracellular Vesicles From SARS-CoV-2 Infected Specimens: A Safety Perspective
por: Nunez Lopez, Yury O., et al.
Publicado: (2021)

Anti‐SARS‐CoV‐2 effect of extracellular vesicles released from mesenchymal stem cells
por: Chutipongtanate, Somchai, et al.
Publicado: (2022)

ACE2‐enriched extracellular vesicles enhance infectivity of live SARS‐CoV‐2 virus
por: Tey, Sze Keong, et al.
Publicado: (2022)

Wearables in the SARS-CoV-2 Pandemic: What Are They Good for?
por: Bent, Brinnae, et al.
Publicado: (2020)

Unravelling the origin of SARS-CoV-2: is the model good?
por: Frutos, R., et al.
Publicado: (2021)

Is the Patient Infected with SARS-CoV-2?
por: Klausner, Jeffrey D., et al.
Publicado: (2021)

Fundamentals of SARS-CoV-2 Biosensors
por: Torres-Torres, Carlos, et al.
Publicado: (2022)

Terrific cells for SARS-CoV-2
por: Gottschalk, Stephen
Publicado: (2022)

Novel SARS-CoV-2 Variants in Italy: The Role of Veterinary Public Health Institutes
por: Lorusso, Alessio, et al.
Publicado: (2021)

Extracellular Vesicles in Phylogeny
por: Lange, Sigrun
Publicado: (2023)

Elucidating design principles for engineering cell-derived vesicles to inhibit SARS-CoV-2 infection
por: Gunnels, Taylor F., et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_e5r2pen4ofhisom5999443v4r4